Diener HC: RPR100893, a substance-P antagonist, is not effective in the treatment of migraine attacks. In: Cephalalgia. 23. Jahrgang, Nr.3, April 2003, S.183–185, PMID 12662184.
Campbell EA, Gentry C, Patel S, et al.: Oral anti-hyperalgesic and anti-inflammatory activity of NK(1) receptor antagonists in models of inflammatory hyperalgesia of the guinea-pig. In: Pain. 87. Jahrgang, Nr.3, September 2000, S.253–263, PMID 10963905.
Lee WS, Moussaoui SM, Moskowitz MA: Blockade by oral or parenteral RPR 100893 (a non-peptide NK1 receptor antagonist) of neurogenic plasma protein extravasation within guinea-pig dura mater and conjunctiva. In: Br. J. Pharmacol. 112. Jahrgang, Nr.3, Juli 1994, S.920–924, PMID 7921621, PMC 1910223 (freier Volltext).
